Viking Therapeutics, Inc.VKTXNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank23
3Y CAGR-1.7%
5Y CAGR-12.0%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-1.7%/yr
vs -43.1%/yr prior
5Y CAGR
-12.0%/yr
Recent acceleration
Acceleration
+41.4pp
Accelerating
Percentile
P23
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $56000.00 | -40.4% |
| 2024 | $94000.00 | +6.8% |
| 2023 | $88000.00 | +49.2% |
| 2022 | $59000.00 | +227.8% |
| 2021 | $18000.00 | -83.0% |
| 2020 | $106000.00 | -27.4% |
| 2019 | $146000.00 | -74.0% |
| 2018 | $562000.00 | -71.2% |
| 2017 | $1.95M | -4.0% |
| 2016 | $2.03M | - |